Angina, Peripheral Arterial Disease and Stent

Johnson and Johnson to Acquire Shockwave Medical

DAIC

APRIL 5, 2024

With the addition of Shockwave, Johnson & Johnson will expand its MedTech cardiovascular portfolio into two of the highest-growth, innovation-oriented segments of cardiovascular intervention – coronary artery disease (CAD) and peripheral artery disease (PAD). The Reducer System has a growing commercial presence.

Cardiovascular Interventions

Cardiovascular Interventions Technology Innovation Angina

Rise of the Lysenkoist Cardiologists

Dr. Anish Koka

MAY 16, 2023

Not surprisingly, a dataset of coronary angiograms and chest pain syndromes showed that the more classic the chest pain syndrome was, the higher the likelihood that angiographic coronary disease was present. Atypical angina is classified as having any two of the three symptoms, and non-anginal pain any one of the three symptoms.

Chest Pain

Chest Pain Coronary Artery Disease Cancer Heart Attack

Cardiovascular Update

Johnson and Johnson to Acquire Shockwave Medical

Rise of the Lysenkoist Cardiologists

Webinars

Stay Connected